The pathology was reviewed of the early deaths identified from the first 50 neonates treated with extracorporeal membrane
by which the 50 neonates were recruited. Numerical indices of disease severity were used to identify infants who were sufficiently ill to warrant ECMO. The required values were drawn from experience in the USA. In practice, however, these values had often been far exceeded at the point of referral and the patients were referred when their doctors felt that conventional treatment had little more to contribute .5 Precise details about the techniques used in establishing and maintaining extracorporeal life support have been detailed elsewhere. ' 2 In summary, the patient receives a venoarterial cannulation for cardiopulmonary support or a venovenous cannulation for support purely with gas exchange. In the neonatal age group, venoarterial cannulation is achieved surgically from a cervical approach and uses the right internal jugular vein and common carotid artery. Venovenous cannulation is achieved using a 14 French gauge double lumen cannula inserted in the right internal jugular vein. Blood drains from the venous cannula to a small reservoir or 'bladder', from which it is drawn and pumped through a membrane oxygenator, where gas exchange takes place.
Before being returned to the patient the blood passes through a heat exchanger. As pulmonary function improves the rate of blood flow through the circuit is reduced in accordance with estimates of the adequacy of tissue oxygen delivery. Finally, when ECMO support is no longer required, the patient is decannulated, sometimes with repair of the vascular access site(s).
During ECMO, modest anticoagulation was achieved with heparin. The whole blood activated clotting time was maintained between 160 and 200 seconds, and platelet consumption within the circuit was compensated by regular transfusion. Daily cranial and cardiac ultrasound examinations formed part of the clinical monitoring. Results Table 2 gives the characteristics of the first 50 neonates treated by ECMO. The infants who died were not significantly different from the population of neonates treated with ECMO as a whole in terms of descriptive data. The gestational ages ranged from 35 to 42 weeks. Birth weights were between 1800 g and 4300 g (mean 3290 g) and indices of disease severity at referral were not significantly different from those who survived to discharge from Leicester. Two of the neonates were siblings. Ten of the neonates entered the ECMO programme in the early neonatal period for disorders noted at birth, which did not respond to conventional treatment. Two had been discharged home and were readmitted at eight and 17 days with viral pneumonia and. pneumococcal septicaemia respectively. Again, ECMO was instituted when they did not respond to maximum conventional treatment. Age at referral varied from 11 to 504 hours. Survivors were noted to be significantly younger at referral, but this difference arose from the fact that the two neonates with community acquired infection both died; these infants were older. Seven of the infants who died had received venoarterial cannulation and one of the remaining infants required conversion from venovenous cannulation to venoarterial ECMO after 250 hours of perfusion. The duration of ECMO varied from 57 to 405 hours (mean 122 hours). Survivors had received ECMO for a significantly shorter period than those who died (mean 104 hours compared with 169 hours). Table 3 shows details of the primary diagnosis and cause of death in the 12 infants who died.
Support was withdrawn in eight patients. In two patients this was because of catastrophic haemorrhage while receiving ECMO. In six patients withdrawal was due to severe cerebral ischaemic damage or haemorrhage noted on cranial ultrasound, or a general deterioration. Four died a few days after apparently successful treatment. All of these four infants received ventilation after ECMO, and in one the death was due to the presenting disorder (severe sepsis), with pneumococcus isolated. Five neonates had lesions reflecting severe cerebral ischaemia, including multiple foci of periventricular leukomalacia, and in two patients there was widespread cystic degeneration; one showed early focal periventricular leukomalacia. Four had haemorrhage within the cerebellum, ranging from a solitary focal lesion (0 5 cm diameter in one patient) to complete haemorrhagic necrosis of the cerebellum (two patients). One of these latter patients also had an associated bilateral interventricular haemorrhage. In this patient it was thought that the changes seen were of such an age as to have occurred before the start of ECMO. Three of the infants dying of haemorrhage showed evidence of sepsis at necropsy.
All the neonates had squamous metaplasia of the trachea and evidence of severe lung disease, ranging from thickened alveolar walls due to oedema or fibrosis, or both, with hyaline membrane formation (seven infants), to more severe changes, including large focal pulmonary haemorrhages up to 5 cm across, desquamation, and necrosis (four infants). The patient who presented with pneumococcal septicaemia had multiple pulmonary abscesses. Table 4 summarises the significant pulmonary findings. Three neonates showed evidence of myocardial ischaemia, ranging from a minor degree of subendocardial and papillary muscle ischaemia (two infants) to extensive infarction Reperfusion injury is another postulated mechanism by which bypass may contribute to tissue damage -for example, it might be anticipated that infants who are to varying degrees acidotic, hypotensive, hypoxic and poorly perfused would be at risk of widespread free radical production during reperfusion. Such a mechanism has been implicated in the aetiology of myocardial stun.7 In this instance we might expect to see differences between '7 - in addition to those infants referred too late for successful treatment by any means. As our knowledge of these entities improves, we may be able to predict outcome by a lung biopsy before ECMO, as has been advocated. '8 19 No unexpected pulmonary diagnoses were detected in the four patients with persistent pulmonary hypertension who died in this series.
Many of the pathological changes observed were far more extensive than are usually seen in similar infants dying after intensive care -for example, marked thickening and fibrosis of alveolar walls, extensive haemorrhage in lungs and brain, and the extent and severity of the ischaemic brain damage. In addition to the severity of presentation this may be because ECMO provides a means of supporting these infants beyond the time when death would have otherwise occurred, thus allowing progression of the pathological findings. To produce accurate discriminatory data it would be necessary to compare pathological findings in a study of patients whose treatment had been subject to random allocation. In this context, pathology has much to contribute to the delineation of the role of ECMO in neonatal practice. 
